{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:41:50Z","timestamp":1782772910196,"version":"3.54.5"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1097\/mca.0000000000000378","type":"journal-article","created":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T12:45:48Z","timestamp":1461847548000},"page":"385-390","source":"Crossref","is-referenced-by-count":0,"title":["Long-term clinical impact of polymer-free sirolimus-eluting stents in unselected patients"],"prefix":"10.1097","volume":"27","author":[{"given":"Nakul","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cassese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210204","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"R2-7-20210204","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2015.04.017","article-title":"Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"65","author":"Palmerini","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R3-7-20210204","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1093\/eurheartj\/ehv511","article-title":"Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gruntzig Lecture ESC 2014","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur Heart J"},{"key":"R4-7-20210204","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1210816","article-title":"Drug-eluting coronary-artery stents","volume":"368","author":"Stefanini","year":"2013","journal-title":"N Engl J Med"},{"key":"R5-7-20210204","first-page":"567","article-title":"Polymer coatings and delayed arterial healing following drug-eluting stent implantation","volume":"57","author":"Byrne","year":"2009","journal-title":"Minerva Cardioangiol"},{"key":"R6-7-20210204","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1253\/circj.CJ-10-0738","article-title":"ISAR \u2013 a story of trials with impact on practice","volume":"74","author":"Schulz","year":"2010","journal-title":"Circ J"},{"key":"R7-7-20210204","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/eurheartj\/ehi405","article-title":"Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating","volume":"26","author":"Hausleiter","year":"2005","journal-title":"Eur Heart J"},{"key":"R8-7-20210204","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.ATV.0000157579.52566.ee","article-title":"Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating","volume":"25","author":"Wessely","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R9-7-20210204","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"R10-7-20210204","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.104.508937","article-title":"Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents","volume":"112","author":"Finn","year":"2005","journal-title":"Circulation"},{"key":"R11-7-20210204","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jcin.2015.09.008","article-title":"Polymer-free biolimus A9-coated stents in the treatment of de novo coronary lesions: 4- and 12-month angiographic follow-up and final 5-year clinical outcomes of the prospective, Multicenter Biofreedom FIM clinical trial","volume":"9","author":"Costa","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"R12-7-20210204","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcin.2015.09.020","article-title":"A randomized comparison of reservoir-based polymer-free amphilimus-eluting stents versus everolimus-eluting stents with durable polymer in patients with diabetes mellitus: the RESERVOIR clinical trial","volume":"9","author":"Romaguera","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"R13-7-20210204","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free drug-coated coronary stents in patients at high bleeding risk","volume":"373","author":"Urban","year":"2015","journal-title":"N Engl J Med"},{"key":"R14-7-20210204","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/CIRCULATIONAHA.105.575977","article-title":"Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss","volume":"113","author":"Mehilli","year":"2006","journal-title":"Circulation"},{"key":"R15-7-20210204","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1002\/ccd.24375","article-title":"Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: final results of the intracoronary stenting and angiographic restenosis \u2013 test equivalence between two drug-eluting stents (ISAR-TEST) trial","volume":"81","author":"King","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"R16-7-20210204","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jcin.2010.11.016","article-title":"Randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus: the LIPSIA Yukon trial","volume":"4","author":"Desch","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"R17-7-20210204","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ccd.25131","article-title":"Five-year clinical follow-up of a randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus (LIPSIA Yukon trial)","volume":"83","author":"Stiermaier","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"R18-7-20210204","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.recesp.2012.11.017","article-title":"Polymer-free sirolimus-eluting versus polymer-based paclitaxel-eluting stents: an individual patient data analysis of randomized trials","volume":"66","author":"Cassese","year":"2013","journal-title":"Rev Esp Cardiol"},{"key":"R19-7-20210204","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.jacc.2010.03.020","article-title":"2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents","volume":"55","author":"Byrne","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R20-7-20210204","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1136\/hrt.2009.172379","article-title":"Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results","volume":"95","author":"Byrne","year":"2009","journal-title":"Heart"},{"key":"R21-7-20210204","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0002-8703(03)00435-6","article-title":"Impact of lesion complexity on the capacity of a trial to detect differences in stent performance: results from the ISAR-STEREO trial","volume":"146","author":"Hausleiter","year":"2003","journal-title":"Am Heart J"},{"key":"R22-7-20210204","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/ccd.25272","article-title":"Incidence of adverse cardiac events 5 years after polymer-free sirolimus eluting stent implantation: results from the prospective Bad Berka Yukon Choice registry","volume":"84","author":"Ohlow","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"R23-7-20210204","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jcin.2008.11.015","article-title":"Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer","volume":"2","author":"Byrne","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"R24-7-20210204","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings","volume":"123","author":"Kolandaivelu","year":"2011","journal-title":"Circulation"},{"key":"R25-7-20210204","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCINTERVENTIONS.111.967083","article-title":"Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials","volume":"5","author":"Palmerini","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"R26-7-20210204","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1161\/CIRCULATIONAHA.108.790048","article-title":"Cardiovascular disease and risk factors in Asia: a selected review","volume":"118","author":"Ueshima","year":"2008","journal-title":"Circulation"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000378","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:40:40Z","timestamp":1620960040000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019501-201608000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000378","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}